
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PSF CRISPR/Cas9 KO Plasmid (m) | sc-427964 | 20 µg | $397.00 |
Sfpq encodes the splicing factor proline- and glutamine-rich protein PSF, a multifunctional RNA- and DNA-binding regulator that coordinates pre-mRNA splicing, transcriptional control, and nuclear paraspeckle biology through interactions with long noncoding RNAs such as NEAT1. In mouse cells, PSF contributes to RNA processing fidelity, alternative splicing decisions, and coupling between transcription and RNA maturation, while also participating in genome maintenance processes linked to DNA damage responses. Through these activities, Sfpq influences broad gene expression programs affecting cell cycle control, neuronal differentiation, and stress-adaptive signaling. Dysregulated SFPQ/PSF function and mislocalization have been associated with altered RNA metabolism and neurodegeneration-relevant phenotypes, making it a useful target for mechanistic studies of RNA-binding protein networks.
PSF CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sfpq gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sfpq together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sfpq open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PSF protein expression.
This CRISPR knockout system enables efficient generation of Sfpq-deficient cell models for investigation of PSF signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.